NEW YORK, June 5, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of UroGen Pharma Ltd. (NASDAQ: URGN) between July 27, 2023 and May 15, 2025, both dates inclusive (the "Class...
Hence then, the article about urgn investors have opportunity to lead urogen pharma ltd securities fraud lawsuit was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( URGN Investors Have Opportunity to Lead UroGen Pharma Ltd. Securities Fraud Lawsuit )
Also on site :
- Union boss ‘held up Communist flag alongside people singing pro-Russia chants in occupied Ukraine’
- Large house fire near Buckeye Lake kills one, critically injures second victim
- Regained momentum sets Yemen government’s eyes on Houthis in the north